nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—Dimetacrine—Tamoxifen—pancreatic cancer	0.157	0.571	CrCrCtD
Desipramine—Promazine—Tamoxifen—pancreatic cancer	0.118	0.429	CrCrCtD
Desipramine—SLC22A3—Irinotecan—pancreatic cancer	0.0635	0.128	CbGbCtD
Desipramine—ORM1—Erlotinib—pancreatic cancer	0.0504	0.102	CbGbCtD
Desipramine—CYP2A6—Tamoxifen—pancreatic cancer	0.039	0.0789	CbGbCtD
Desipramine—CYP2E1—Dacarbazine—pancreatic cancer	0.0324	0.0655	CbGbCtD
Desipramine—CYP2A6—Fluorouracil—pancreatic cancer	0.0288	0.0582	CbGbCtD
Desipramine—CYP2E1—Tamoxifen—pancreatic cancer	0.0258	0.0521	CbGbCtD
Desipramine—CYP2B6—Tamoxifen—pancreatic cancer	0.0254	0.0514	CbGbCtD
Desipramine—CYP2B6—Irinotecan—pancreatic cancer	0.0195	0.0395	CbGbCtD
Desipramine—CYP1A2—Dacarbazine—pancreatic cancer	0.0187	0.0379	CbGbCtD
Desipramine—CYP2C19—Tamoxifen—pancreatic cancer	0.0162	0.0326	CbGbCtD
Desipramine—CYP1A2—Tamoxifen—pancreatic cancer	0.0149	0.0301	CbGbCtD
Desipramine—ABCB1—Tamoxifen—pancreatic cancer	0.013	0.0263	CbGbCtD
Desipramine—CYP1A2—Erlotinib—pancreatic cancer	0.0127	0.0256	CbGbCtD
Desipramine—CYP2D6—Tamoxifen—pancreatic cancer	0.0123	0.0248	CbGbCtD
Desipramine—ABCB1—Gemcitabine—pancreatic cancer	0.0112	0.0227	CbGbCtD
Desipramine—ABCB1—Erlotinib—pancreatic cancer	0.0111	0.0224	CbGbCtD
Desipramine—CYP1A2—Fluorouracil—pancreatic cancer	0.011	0.0222	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—pancreatic cancer	0.0107	0.0216	CbGbCtD
Desipramine—CYP2D6—Erlotinib—pancreatic cancer	0.0104	0.0211	CbGbCtD
Desipramine—ABCB1—Irinotecan—pancreatic cancer	0.01	0.0202	CbGbCtD
Desipramine—CYP3A4—Tamoxifen—pancreatic cancer	0.00781	0.0158	CbGbCtD
Desipramine—ABCB1—Docetaxel—pancreatic cancer	0.00733	0.0148	CbGbCtD
Desipramine—ABCB1—Sunitinib—pancreatic cancer	0.0073	0.0148	CbGbCtD
Desipramine—CYP3A4—Erlotinib—pancreatic cancer	0.00664	0.0134	CbGbCtD
Desipramine—CYP3A4—Irinotecan—pancreatic cancer	0.006	0.0121	CbGbCtD
Desipramine—ABCB1—Doxorubicin—pancreatic cancer	0.00547	0.0111	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—pancreatic cancer	0.00515	0.0104	CbGbCtD
Desipramine—CYP3A4—Docetaxel—pancreatic cancer	0.00439	0.00888	CbGbCtD
Desipramine—CYP3A4—Sunitinib—pancreatic cancer	0.00437	0.00884	CbGbCtD
Desipramine—CYP3A4—Doxorubicin—pancreatic cancer	0.00328	0.00662	CbGbCtD
Desipramine—ORM1—bile—pancreatic cancer	0.00245	0.251	CbGeAlD
Desipramine—HTR2A—enteric nervous system—pancreatic cancer	0.0021	0.215	CbGeAlD
Desipramine—SMPD1—islet of Langerhans—pancreatic cancer	0.000911	0.0933	CbGeAlD
Desipramine—ORM1—gall bladder—pancreatic cancer	0.00068	0.0697	CbGeAlD
Desipramine—SMPD1—digestive system—pancreatic cancer	0.000547	0.056	CbGeAlD
Desipramine—CYP2C18—digestive system—pancreatic cancer	0.000445	0.0456	CbGeAlD
Desipramine—SLC22A2—digestive system—pancreatic cancer	0.000347	0.0356	CbGeAlD
Desipramine—SLC22A4—digestive system—pancreatic cancer	0.000258	0.0264	CbGeAlD
Desipramine—Decreased appetite—Sunitinib—pancreatic cancer	0.000252	0.00228	CcSEcCtD
Desipramine—Fatigue—Sunitinib—pancreatic cancer	0.00025	0.00227	CcSEcCtD
Desipramine—Constipation—Sunitinib—pancreatic cancer	0.000248	0.00225	CcSEcCtD
Desipramine—Discomfort—Irinotecan—pancreatic cancer	0.000246	0.00223	CcSEcCtD
Desipramine—Hypertension—Gemcitabine—pancreatic cancer	0.000246	0.00223	CcSEcCtD
Desipramine—Asthenia—Tamoxifen—pancreatic cancer	0.000243	0.0022	CcSEcCtD
Desipramine—Convulsion—Fluorouracil—pancreatic cancer	0.000243	0.0022	CcSEcCtD
Desipramine—Agranulocytosis—Docetaxel—pancreatic cancer	0.000242	0.00219	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Doxorubicin—pancreatic cancer	0.000241	0.00218	CcSEcCtD
Desipramine—Confusional state—Irinotecan—pancreatic cancer	0.000241	0.00218	CcSEcCtD
Desipramine—Asthenia—Erlotinib—pancreatic cancer	0.000241	0.00218	CcSEcCtD
Desipramine—Discomfort—Gemcitabine—pancreatic cancer	0.00024	0.00217	CcSEcCtD
Desipramine—Pruritus—Tamoxifen—pancreatic cancer	0.00024	0.00217	CcSEcCtD
Desipramine—Oedema—Irinotecan—pancreatic cancer	0.000239	0.00216	CcSEcCtD
Desipramine—Pruritus—Erlotinib—pancreatic cancer	0.000237	0.00215	CcSEcCtD
Desipramine—Discomfort—Fluorouracil—pancreatic cancer	0.000236	0.00214	CcSEcCtD
Desipramine—Purpura—Epirubicin—pancreatic cancer	0.000235	0.00213	CcSEcCtD
Desipramine—Vascular purpura—Doxorubicin—pancreatic cancer	0.000235	0.00212	CcSEcCtD
Desipramine—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000234	0.00212	CcSEcCtD
Desipramine—Oedema—Gemcitabine—pancreatic cancer	0.000233	0.00211	CcSEcCtD
Desipramine—Hepatitis—Docetaxel—pancreatic cancer	0.000233	0.00211	CcSEcCtD
Desipramine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000232	0.0021	CcSEcCtD
Desipramine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000231	0.0021	CcSEcCtD
Desipramine—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000231	0.0021	CcSEcCtD
Desipramine—Confusional state—Fluorouracil—pancreatic cancer	0.000231	0.00209	CcSEcCtD
Desipramine—Body temperature increased—Sunitinib—pancreatic cancer	0.000229	0.00208	CcSEcCtD
Desipramine—Abdominal pain—Sunitinib—pancreatic cancer	0.000229	0.00208	CcSEcCtD
Desipramine—Diarrhoea—Erlotinib—pancreatic cancer	0.000229	0.00208	CcSEcCtD
Desipramine—Oedema—Fluorouracil—pancreatic cancer	0.000229	0.00207	CcSEcCtD
Desipramine—SLC6A4—digestive system—pancreatic cancer	0.000228	0.0234	CbGeAlD
Desipramine—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000228	0.00206	CcSEcCtD
Desipramine—Anorexia—Irinotecan—pancreatic cancer	0.000228	0.00206	CcSEcCtD
Desipramine—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000224	0.00203	CcSEcCtD
Desipramine—Dizziness—Tamoxifen—pancreatic cancer	0.000224	0.00203	CcSEcCtD
Desipramine—Tachycardia—Fluorouracil—pancreatic cancer	0.000223	0.00202	CcSEcCtD
Desipramine—Hypotension—Irinotecan—pancreatic cancer	0.000223	0.00202	CcSEcCtD
Desipramine—Anorexia—Gemcitabine—pancreatic cancer	0.000222	0.00201	CcSEcCtD
Desipramine—Dizziness—Erlotinib—pancreatic cancer	0.000222	0.00201	CcSEcCtD
Desipramine—Anorexia—Fluorouracil—pancreatic cancer	0.000218	0.00198	CcSEcCtD
Desipramine—Purpura—Doxorubicin—pancreatic cancer	0.000218	0.00197	CcSEcCtD
Desipramine—Hypotension—Gemcitabine—pancreatic cancer	0.000218	0.00197	CcSEcCtD
Desipramine—Insomnia—Irinotecan—pancreatic cancer	0.000216	0.00196	CcSEcCtD
Desipramine—Flushing—Docetaxel—pancreatic cancer	0.000216	0.00195	CcSEcCtD
Desipramine—Vomiting—Tamoxifen—pancreatic cancer	0.000215	0.00195	CcSEcCtD
Desipramine—Paraesthesia—Irinotecan—pancreatic cancer	0.000215	0.00194	CcSEcCtD
Desipramine—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000214	0.00194	CcSEcCtD
Desipramine—Hypotension—Fluorouracil—pancreatic cancer	0.000214	0.00194	CcSEcCtD
Desipramine—Rash—Tamoxifen—pancreatic cancer	0.000214	0.00193	CcSEcCtD
Desipramine—Dermatitis—Tamoxifen—pancreatic cancer	0.000213	0.00193	CcSEcCtD
Desipramine—Ataxia—Epirubicin—pancreatic cancer	0.000213	0.00193	CcSEcCtD
Desipramine—Vomiting—Erlotinib—pancreatic cancer	0.000213	0.00193	CcSEcCtD
Desipramine—Somnolence—Irinotecan—pancreatic cancer	0.000213	0.00192	CcSEcCtD
Desipramine—Headache—Tamoxifen—pancreatic cancer	0.000212	0.00192	CcSEcCtD
Desipramine—Rash—Erlotinib—pancreatic cancer	0.000211	0.00191	CcSEcCtD
Desipramine—Dermatitis—Erlotinib—pancreatic cancer	0.000211	0.00191	CcSEcCtD
Desipramine—Insomnia—Gemcitabine—pancreatic cancer	0.000211	0.00191	CcSEcCtD
Desipramine—Dyspepsia—Irinotecan—pancreatic cancer	0.00021	0.00191	CcSEcCtD
Desipramine—Headache—Erlotinib—pancreatic cancer	0.00021	0.0019	CcSEcCtD
Desipramine—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000209	0.0019	CcSEcCtD
Desipramine—Paraesthesia—Gemcitabine—pancreatic cancer	0.000209	0.00189	CcSEcCtD
Desipramine—Asthenia—Sunitinib—pancreatic cancer	0.000208	0.00189	CcSEcCtD
Desipramine—Decreased appetite—Irinotecan—pancreatic cancer	0.000208	0.00188	CcSEcCtD
Desipramine—Arrhythmia—Docetaxel—pancreatic cancer	0.000208	0.00188	CcSEcCtD
Desipramine—Insomnia—Fluorouracil—pancreatic cancer	0.000207	0.00188	CcSEcCtD
Desipramine—Somnolence—Gemcitabine—pancreatic cancer	0.000207	0.00187	CcSEcCtD
Desipramine—Fatigue—Irinotecan—pancreatic cancer	0.000206	0.00187	CcSEcCtD
Desipramine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000206	0.00186	CcSEcCtD
Desipramine—Alopecia—Docetaxel—pancreatic cancer	0.000206	0.00186	CcSEcCtD
Desipramine—Pruritus—Sunitinib—pancreatic cancer	0.000205	0.00186	CcSEcCtD
Desipramine—Constipation—Irinotecan—pancreatic cancer	0.000204	0.00185	CcSEcCtD
Desipramine—Somnolence—Fluorouracil—pancreatic cancer	0.000204	0.00184	CcSEcCtD
Desipramine—CHRM3—digestive system—pancreatic cancer	0.000203	0.0208	CbGeAlD
Desipramine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000202	0.00183	CcSEcCtD
Desipramine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000202	0.00183	CcSEcCtD
Desipramine—Nausea—Tamoxifen—pancreatic cancer	0.000201	0.00182	CcSEcCtD
Desipramine—Fatigue—Gemcitabine—pancreatic cancer	0.000201	0.00182	CcSEcCtD
Desipramine—Constipation—Gemcitabine—pancreatic cancer	0.000199	0.0018	CcSEcCtD
Desipramine—Nausea—Erlotinib—pancreatic cancer	0.000199	0.0018	CcSEcCtD
Desipramine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000199	0.0018	CcSEcCtD
Desipramine—Diarrhoea—Sunitinib—pancreatic cancer	0.000199	0.0018	CcSEcCtD
Desipramine—Dysgeusia—Docetaxel—pancreatic cancer	0.000198	0.0018	CcSEcCtD
Desipramine—Ataxia—Doxorubicin—pancreatic cancer	0.000197	0.00179	CcSEcCtD
Desipramine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000197	0.00178	CcSEcCtD
Desipramine—Eosinophilia—Epirubicin—pancreatic cancer	0.000194	0.00176	CcSEcCtD
Desipramine—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000194	0.00175	CcSEcCtD
Desipramine—Dizziness—Sunitinib—pancreatic cancer	0.000192	0.00174	CcSEcCtD
Desipramine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000192	0.00174	CcSEcCtD
Desipramine—CYP2C19—digestive system—pancreatic cancer	0.000189	0.0194	CbGeAlD
Desipramine—Abdominal pain—Irinotecan—pancreatic cancer	0.000189	0.00171	CcSEcCtD
Desipramine—Body temperature increased—Irinotecan—pancreatic cancer	0.000189	0.00171	CcSEcCtD
Desipramine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000189	0.00171	CcSEcCtD
Desipramine—Vomiting—Sunitinib—pancreatic cancer	0.000185	0.00167	CcSEcCtD
Desipramine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000184	0.00167	CcSEcCtD
Desipramine—Rash—Sunitinib—pancreatic cancer	0.000183	0.00166	CcSEcCtD
Desipramine—Dermatitis—Sunitinib—pancreatic cancer	0.000183	0.00166	CcSEcCtD
Desipramine—Urticaria—Fluorouracil—pancreatic cancer	0.000182	0.00165	CcSEcCtD
Desipramine—Headache—Sunitinib—pancreatic cancer	0.000182	0.00165	CcSEcCtD
Desipramine—Pollakiuria—Epirubicin—pancreatic cancer	0.000181	0.00164	CcSEcCtD
Desipramine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000181	0.00164	CcSEcCtD
Desipramine—Eosinophilia—Doxorubicin—pancreatic cancer	0.00018	0.00163	CcSEcCtD
Desipramine—Palpitations—Docetaxel—pancreatic cancer	0.000179	0.00162	CcSEcCtD
Desipramine—Weight increased—Epirubicin—pancreatic cancer	0.000178	0.00162	CcSEcCtD
Desipramine—Convulsion—Docetaxel—pancreatic cancer	0.000175	0.00159	CcSEcCtD
Desipramine—Hypertension—Docetaxel—pancreatic cancer	0.000175	0.00158	CcSEcCtD
Desipramine—Drowsiness—Epirubicin—pancreatic cancer	0.000175	0.00158	CcSEcCtD
Desipramine—Nausea—Sunitinib—pancreatic cancer	0.000172	0.00156	CcSEcCtD
Desipramine—Asthenia—Irinotecan—pancreatic cancer	0.000172	0.00155	CcSEcCtD
Desipramine—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000171	0.00155	CcSEcCtD
Desipramine—SLC22A5—digestive system—pancreatic cancer	0.00017	0.0175	CbGeAlD
Desipramine—Stomatitis—Epirubicin—pancreatic cancer	0.00017	0.00154	CcSEcCtD
Desipramine—Jaundice—Epirubicin—pancreatic cancer	0.00017	0.00154	CcSEcCtD
Desipramine—Dry mouth—Docetaxel—pancreatic cancer	0.000169	0.00153	CcSEcCtD
Desipramine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000168	0.00152	CcSEcCtD
Desipramine—Asthenia—Gemcitabine—pancreatic cancer	0.000167	0.00151	CcSEcCtD
Desipramine—Confusional state—Docetaxel—pancreatic cancer	0.000167	0.00151	CcSEcCtD
Desipramine—Oedema—Docetaxel—pancreatic cancer	0.000165	0.0015	CcSEcCtD
Desipramine—Weight increased—Doxorubicin—pancreatic cancer	0.000165	0.00149	CcSEcCtD
Desipramine—Pruritus—Gemcitabine—pancreatic cancer	0.000165	0.00149	CcSEcCtD
Desipramine—Diarrhoea—Irinotecan—pancreatic cancer	0.000164	0.00148	CcSEcCtD
Desipramine—Agranulocytosis—Epirubicin—pancreatic cancer	0.000163	0.00148	CcSEcCtD
Desipramine—Pruritus—Fluorouracil—pancreatic cancer	0.000162	0.00147	CcSEcCtD
Desipramine—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000162	0.00147	CcSEcCtD
Desipramine—Drowsiness—Doxorubicin—pancreatic cancer	0.000162	0.00146	CcSEcCtD
Desipramine—Tachycardia—Docetaxel—pancreatic cancer	0.000161	0.00146	CcSEcCtD
Desipramine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000159	0.00144	CcSEcCtD
Desipramine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000159	0.00144	CcSEcCtD
Desipramine—Dizziness—Irinotecan—pancreatic cancer	0.000158	0.00143	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—pancreatic cancer	0.000158	0.00143	CcSEcCtD
Desipramine—Stomatitis—Doxorubicin—pancreatic cancer	0.000158	0.00143	CcSEcCtD
Desipramine—Anorexia—Docetaxel—pancreatic cancer	0.000158	0.00143	CcSEcCtD
Desipramine—Hepatitis—Epirubicin—pancreatic cancer	0.000157	0.00142	CcSEcCtD
Desipramine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000157	0.00142	CcSEcCtD
Desipramine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000156	0.00141	CcSEcCtD
Desipramine—Hypotension—Docetaxel—pancreatic cancer	0.000154	0.0014	CcSEcCtD
Desipramine—CYP1A2—digestive system—pancreatic cancer	0.000154	0.0158	CbGeAlD
Desipramine—Vomiting—Irinotecan—pancreatic cancer	0.000152	0.00138	CcSEcCtD
Desipramine—Dizziness—Fluorouracil—pancreatic cancer	0.000151	0.00137	CcSEcCtD
Desipramine—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000151	0.00137	CcSEcCtD
Desipramine—Rash—Irinotecan—pancreatic cancer	0.000151	0.00136	CcSEcCtD
Desipramine—Dermatitis—Irinotecan—pancreatic cancer	0.000151	0.00136	CcSEcCtD
Desipramine—Headache—Irinotecan—pancreatic cancer	0.00015	0.00136	CcSEcCtD
Desipramine—Insomnia—Docetaxel—pancreatic cancer	0.000149	0.00135	CcSEcCtD
Desipramine—Paraesthesia—Docetaxel—pancreatic cancer	0.000148	0.00134	CcSEcCtD
Desipramine—Vomiting—Gemcitabine—pancreatic cancer	0.000148	0.00134	CcSEcCtD
Desipramine—CYP2B6—digestive system—pancreatic cancer	0.000148	0.0152	CbGeAlD
Desipramine—Somnolence—Docetaxel—pancreatic cancer	0.000147	0.00133	CcSEcCtD
Desipramine—Rash—Gemcitabine—pancreatic cancer	0.000147	0.00133	CcSEcCtD
Desipramine—Dermatitis—Gemcitabine—pancreatic cancer	0.000147	0.00133	CcSEcCtD
Desipramine—Tinnitus—Epirubicin—pancreatic cancer	0.000146	0.00132	CcSEcCtD
Desipramine—Headache—Gemcitabine—pancreatic cancer	0.000146	0.00132	CcSEcCtD
Desipramine—Flushing—Epirubicin—pancreatic cancer	0.000146	0.00132	CcSEcCtD
Desipramine—Vomiting—Fluorouracil—pancreatic cancer	0.000146	0.00132	CcSEcCtD
Desipramine—Dyspepsia—Docetaxel—pancreatic cancer	0.000145	0.00132	CcSEcCtD
Desipramine—Hepatitis—Doxorubicin—pancreatic cancer	0.000145	0.00131	CcSEcCtD
Desipramine—HRH1—digestive system—pancreatic cancer	0.000145	0.0148	CbGeAlD
Desipramine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000144	0.00131	CcSEcCtD
Desipramine—Rash—Fluorouracil—pancreatic cancer	0.000144	0.00131	CcSEcCtD
Desipramine—Dermatitis—Fluorouracil—pancreatic cancer	0.000144	0.00131	CcSEcCtD
Desipramine—Decreased appetite—Docetaxel—pancreatic cancer	0.000144	0.0013	CcSEcCtD
Desipramine—Headache—Fluorouracil—pancreatic cancer	0.000143	0.0013	CcSEcCtD
Desipramine—Fatigue—Docetaxel—pancreatic cancer	0.000142	0.00129	CcSEcCtD
Desipramine—Nausea—Irinotecan—pancreatic cancer	0.000142	0.00129	CcSEcCtD
Desipramine—Constipation—Docetaxel—pancreatic cancer	0.000141	0.00128	CcSEcCtD
Desipramine—Arrhythmia—Epirubicin—pancreatic cancer	0.00014	0.00127	CcSEcCtD
Desipramine—CYP2E1—digestive system—pancreatic cancer	0.000139	0.0142	CbGeAlD
Desipramine—Alopecia—Epirubicin—pancreatic cancer	0.000139	0.00126	CcSEcCtD
Desipramine—Nausea—Gemcitabine—pancreatic cancer	0.000138	0.00125	CcSEcCtD
Desipramine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000136	0.00123	CcSEcCtD
Desipramine—Nausea—Fluorouracil—pancreatic cancer	0.000136	0.00123	CcSEcCtD
Desipramine—Tinnitus—Doxorubicin—pancreatic cancer	0.000135	0.00123	CcSEcCtD
Desipramine—Flushing—Doxorubicin—pancreatic cancer	0.000135	0.00122	CcSEcCtD
Desipramine—Dysgeusia—Epirubicin—pancreatic cancer	0.000134	0.00121	CcSEcCtD
Desipramine—ABCB1—islet of Langerhans—pancreatic cancer	0.000132	0.0135	CbGeAlD
Desipramine—Abdominal pain—Docetaxel—pancreatic cancer	0.000131	0.00118	CcSEcCtD
Desipramine—Body temperature increased—Docetaxel—pancreatic cancer	0.000131	0.00118	CcSEcCtD
Desipramine—Arrhythmia—Doxorubicin—pancreatic cancer	0.00013	0.00117	CcSEcCtD
Desipramine—Vision blurred—Epirubicin—pancreatic cancer	0.000129	0.00117	CcSEcCtD
Desipramine—Alopecia—Doxorubicin—pancreatic cancer	0.000128	0.00116	CcSEcCtD
Desipramine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000127	0.00115	CcSEcCtD
Desipramine—Agitation—Epirubicin—pancreatic cancer	0.000126	0.00114	CcSEcCtD
Desipramine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000124	0.00112	CcSEcCtD
Desipramine—Malaise—Epirubicin—pancreatic cancer	0.000123	0.00112	CcSEcCtD
Desipramine—HTR2A—digestive system—pancreatic cancer	0.000121	0.0124	CbGeAlD
Desipramine—Palpitations—Epirubicin—pancreatic cancer	0.000121	0.00109	CcSEcCtD
Desipramine—Vision blurred—Doxorubicin—pancreatic cancer	0.000119	0.00108	CcSEcCtD
Desipramine—Asthenia—Docetaxel—pancreatic cancer	0.000119	0.00107	CcSEcCtD
Desipramine—Convulsion—Epirubicin—pancreatic cancer	0.000118	0.00107	CcSEcCtD
Desipramine—Hypertension—Epirubicin—pancreatic cancer	0.000118	0.00107	CcSEcCtD
Desipramine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000117	0.00106	CcSEcCtD
Desipramine—Pruritus—Docetaxel—pancreatic cancer	0.000117	0.00106	CcSEcCtD
Desipramine—Agitation—Doxorubicin—pancreatic cancer	0.000116	0.00105	CcSEcCtD
Desipramine—Anxiety—Epirubicin—pancreatic cancer	0.000116	0.00105	CcSEcCtD
Desipramine—Discomfort—Epirubicin—pancreatic cancer	0.000115	0.00104	CcSEcCtD
Desipramine—Malaise—Doxorubicin—pancreatic cancer	0.000114	0.00103	CcSEcCtD
Desipramine—Dry mouth—Epirubicin—pancreatic cancer	0.000114	0.00103	CcSEcCtD
Desipramine—Diarrhoea—Docetaxel—pancreatic cancer	0.000113	0.00102	CcSEcCtD
Desipramine—Confusional state—Epirubicin—pancreatic cancer	0.000112	0.00102	CcSEcCtD
Desipramine—CYP3A4—digestive system—pancreatic cancer	0.000112	0.0114	CbGeAlD
Desipramine—Palpitations—Doxorubicin—pancreatic cancer	0.000112	0.00101	CcSEcCtD
Desipramine—Oedema—Epirubicin—pancreatic cancer	0.000111	0.00101	CcSEcCtD
Desipramine—CYP2D6—digestive system—pancreatic cancer	0.00011	0.0113	CbGeAlD
Desipramine—Convulsion—Doxorubicin—pancreatic cancer	0.000109	0.000991	CcSEcCtD
Desipramine—Dizziness—Docetaxel—pancreatic cancer	0.000109	0.00099	CcSEcCtD
Desipramine—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000109	0.000988	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—pancreatic cancer	0.000109	0.000988	CcSEcCtD
Desipramine—Tachycardia—Epirubicin—pancreatic cancer	0.000109	0.000985	CcSEcCtD
Desipramine—Anxiety—Doxorubicin—pancreatic cancer	0.000107	0.000971	CcSEcCtD
Desipramine—Discomfort—Doxorubicin—pancreatic cancer	0.000106	0.000963	CcSEcCtD
Desipramine—Anorexia—Epirubicin—pancreatic cancer	0.000106	0.000962	CcSEcCtD
Desipramine—Dry mouth—Doxorubicin—pancreatic cancer	0.000105	0.000953	CcSEcCtD
Desipramine—Vomiting—Docetaxel—pancreatic cancer	0.000105	0.000951	CcSEcCtD
Desipramine—Rash—Docetaxel—pancreatic cancer	0.000104	0.000944	CcSEcCtD
Desipramine—Hypotension—Epirubicin—pancreatic cancer	0.000104	0.000943	CcSEcCtD
Desipramine—Dermatitis—Docetaxel—pancreatic cancer	0.000104	0.000943	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—pancreatic cancer	0.000104	0.000942	CcSEcCtD
Desipramine—Headache—Docetaxel—pancreatic cancer	0.000104	0.000937	CcSEcCtD
Desipramine—Oedema—Doxorubicin—pancreatic cancer	0.000103	0.000934	CcSEcCtD
Desipramine—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000101	0.000914	CcSEcCtD
Desipramine—Insomnia—Epirubicin—pancreatic cancer	0.000101	0.000913	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—pancreatic cancer	0.000101	0.000911	CcSEcCtD
Desipramine—Paraesthesia—Epirubicin—pancreatic cancer	0.0001	0.000906	CcSEcCtD
Desipramine—Somnolence—Epirubicin—pancreatic cancer	9.91e-05	0.000897	CcSEcCtD
Desipramine—Anorexia—Doxorubicin—pancreatic cancer	9.83e-05	0.00089	CcSEcCtD
Desipramine—Nausea—Docetaxel—pancreatic cancer	9.82e-05	0.000889	CcSEcCtD
Desipramine—Dyspepsia—Epirubicin—pancreatic cancer	9.81e-05	0.000888	CcSEcCtD
Desipramine—Decreased appetite—Epirubicin—pancreatic cancer	9.69e-05	0.000877	CcSEcCtD
Desipramine—Hypotension—Doxorubicin—pancreatic cancer	9.64e-05	0.000873	CcSEcCtD
Desipramine—Fatigue—Epirubicin—pancreatic cancer	9.61e-05	0.00087	CcSEcCtD
Desipramine—Constipation—Epirubicin—pancreatic cancer	9.53e-05	0.000863	CcSEcCtD
Desipramine—Insomnia—Doxorubicin—pancreatic cancer	9.33e-05	0.000845	CcSEcCtD
Desipramine—ABCB1—pancreas—pancreatic cancer	9.26e-05	0.00949	CbGeAlD
Desipramine—Paraesthesia—Doxorubicin—pancreatic cancer	9.26e-05	0.000839	CcSEcCtD
Desipramine—Feeling abnormal—Epirubicin—pancreatic cancer	9.19e-05	0.000832	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—pancreatic cancer	9.17e-05	0.00083	CcSEcCtD
Desipramine—Dyspepsia—Doxorubicin—pancreatic cancer	9.08e-05	0.000822	CcSEcCtD
Desipramine—Decreased appetite—Doxorubicin—pancreatic cancer	8.97e-05	0.000812	CcSEcCtD
Desipramine—Fatigue—Doxorubicin—pancreatic cancer	8.89e-05	0.000805	CcSEcCtD
Desipramine—Urticaria—Epirubicin—pancreatic cancer	8.86e-05	0.000802	CcSEcCtD
Desipramine—Constipation—Doxorubicin—pancreatic cancer	8.82e-05	0.000799	CcSEcCtD
Desipramine—Abdominal pain—Epirubicin—pancreatic cancer	8.81e-05	0.000798	CcSEcCtD
Desipramine—Body temperature increased—Epirubicin—pancreatic cancer	8.81e-05	0.000798	CcSEcCtD
Desipramine—Feeling abnormal—Doxorubicin—pancreatic cancer	8.5e-05	0.00077	CcSEcCtD
Desipramine—Urticaria—Doxorubicin—pancreatic cancer	8.19e-05	0.000742	CcSEcCtD
Desipramine—Abdominal pain—Doxorubicin—pancreatic cancer	8.15e-05	0.000738	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—pancreatic cancer	8.15e-05	0.000738	CcSEcCtD
Desipramine—Asthenia—Epirubicin—pancreatic cancer	8e-05	0.000724	CcSEcCtD
Desipramine—ABCB1—digestive system—pancreatic cancer	7.91e-05	0.0081	CbGeAlD
Desipramine—Pruritus—Epirubicin—pancreatic cancer	7.89e-05	0.000714	CcSEcCtD
Desipramine—Diarrhoea—Epirubicin—pancreatic cancer	7.63e-05	0.000691	CcSEcCtD
Desipramine—Asthenia—Doxorubicin—pancreatic cancer	7.4e-05	0.00067	CcSEcCtD
Desipramine—Dizziness—Epirubicin—pancreatic cancer	7.37e-05	0.000667	CcSEcCtD
Desipramine—Pruritus—Doxorubicin—pancreatic cancer	7.3e-05	0.000661	CcSEcCtD
Desipramine—Vomiting—Epirubicin—pancreatic cancer	7.09e-05	0.000642	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—pancreatic cancer	7.06e-05	0.000639	CcSEcCtD
Desipramine—Rash—Epirubicin—pancreatic cancer	7.03e-05	0.000636	CcSEcCtD
Desipramine—Dermatitis—Epirubicin—pancreatic cancer	7.02e-05	0.000636	CcSEcCtD
Desipramine—Headache—Epirubicin—pancreatic cancer	6.98e-05	0.000632	CcSEcCtD
Desipramine—Dizziness—Doxorubicin—pancreatic cancer	6.82e-05	0.000618	CcSEcCtD
Desipramine—Nausea—Epirubicin—pancreatic cancer	6.62e-05	0.0006	CcSEcCtD
Desipramine—Vomiting—Doxorubicin—pancreatic cancer	6.56e-05	0.000594	CcSEcCtD
Desipramine—Rash—Doxorubicin—pancreatic cancer	6.5e-05	0.000589	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—pancreatic cancer	6.5e-05	0.000588	CcSEcCtD
Desipramine—Headache—Doxorubicin—pancreatic cancer	6.46e-05	0.000585	CcSEcCtD
Desipramine—Nausea—Doxorubicin—pancreatic cancer	6.13e-05	0.000555	CcSEcCtD
Desipramine—HTR2C—Signaling Pathways—PTEN—pancreatic cancer	3.66e-06	3.31e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	3.66e-06	3.31e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EGFR—pancreatic cancer	3.65e-06	3.3e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	3.65e-06	3.3e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTGS2—pancreatic cancer	3.65e-06	3.3e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	3.62e-06	3.27e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	3.62e-06	3.27e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—KRAS—pancreatic cancer	3.6e-06	3.26e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	3.6e-06	3.25e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—AKT1—pancreatic cancer	3.59e-06	3.25e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.58e-06	3.23e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—AKT1—pancreatic cancer	3.57e-06	3.23e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	3.57e-06	3.23e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—SRC—pancreatic cancer	3.57e-06	3.23e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CXCL8—pancreatic cancer	3.54e-06	3.2e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	3.53e-06	3.19e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—STK11—pancreatic cancer	3.53e-06	3.19e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	3.52e-06	3.18e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—HRAS—pancreatic cancer	3.52e-06	3.18e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	3.51e-06	3.17e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	3.51e-06	3.17e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	3.5e-06	3.16e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—SRC—pancreatic cancer	3.49e-06	3.16e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PPARG—pancreatic cancer	3.49e-06	3.16e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	3.49e-06	3.15e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	3.48e-06	3.14e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	3.47e-06	3.14e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	3.47e-06	3.14e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	3.45e-06	3.12e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—KRAS—pancreatic cancer	3.45e-06	3.12e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	3.44e-06	3.11e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	3.44e-06	3.11e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	3.44e-06	3.11e-05	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	3.42e-06	3.09e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—SRC—pancreatic cancer	3.42e-06	3.09e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	3.41e-06	3.08e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.41e-06	3.08e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	3.4e-06	3.08e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	3.4e-06	3.07e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—SRC—pancreatic cancer	3.4e-06	3.07e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	3.39e-06	3.06e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	3.39e-06	3.06e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	3.38e-06	3.06e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	3.37e-06	3.05e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	3.37e-06	3.05e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	3.36e-06	3.04e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	3.36e-06	3.04e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	3.36e-06	3.03e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	3.35e-06	3.03e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	3.33e-06	3.01e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	3.33e-06	3.01e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	3.32e-06	3e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PIK3CA—pancreatic cancer	3.31e-06	2.99e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	3.31e-06	2.99e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	3.3e-06	2.98e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	3.29e-06	2.98e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	3.29e-06	2.97e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.29e-06	2.97e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	3.29e-06	2.97e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	3.28e-06	2.96e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	3.28e-06	2.96e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	3.27e-06	2.96e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	3.27e-06	2.96e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	3.26e-06	2.95e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	3.26e-06	2.95e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.26e-06	2.94e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	3.25e-06	2.94e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	3.25e-06	2.94e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTEN—pancreatic cancer	3.25e-06	2.93e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	3.24e-06	2.93e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	3.24e-06	2.93e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	3.23e-06	2.92e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	3.21e-06	2.9e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—pancreatic cancer	3.2e-06	2.9e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	3.2e-06	2.89e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—pancreatic cancer	3.2e-06	2.89e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—APOE—pancreatic cancer	3.2e-06	2.89e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	3.19e-06	2.89e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	3.19e-06	2.89e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	3.18e-06	2.88e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	3.18e-06	2.88e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTEN—pancreatic cancer	3.18e-06	2.87e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	3.18e-06	2.87e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	3.18e-06	2.87e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	3.17e-06	2.87e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	3.17e-06	2.87e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	3.17e-06	2.86e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	3.16e-06	2.85e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	3.15e-06	2.85e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	3.14e-06	2.84e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—pancreatic cancer	3.13e-06	2.83e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	3.13e-06	2.83e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	3.12e-06	2.82e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	3.12e-06	2.82e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	3.1e-06	2.81e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	3.1e-06	2.8e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	3.09e-06	2.8e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	3.09e-06	2.79e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	3.08e-06	2.78e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—pancreatic cancer	3.07e-06	2.77e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	3.06e-06	2.77e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	3.06e-06	2.77e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—pancreatic cancer	3.06e-06	2.77e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	3.05e-06	2.76e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	3.05e-06	2.76e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—pancreatic cancer	3.05e-06	2.75e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	3.04e-06	2.75e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.04e-06	2.74e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.03e-06	2.74e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—SRC—pancreatic cancer	3e-06	2.71e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3e-06	2.71e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	2.99e-06	2.71e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	2.98e-06	2.69e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	2.96e-06	2.67e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—SRC—pancreatic cancer	2.95e-06	2.67e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—SRC—pancreatic cancer	2.94e-06	2.66e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	2.94e-06	2.65e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	2.93e-06	2.65e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—SRC—pancreatic cancer	2.93e-06	2.65e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	2.92e-06	2.64e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	2.9e-06	2.62e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	2.89e-06	2.62e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	2.89e-06	2.61e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.89e-06	2.61e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	2.89e-06	2.61e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	2.88e-06	2.61e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	2.87e-06	2.6e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	2.87e-06	2.59e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	2.86e-06	2.58e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	2.85e-06	2.58e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	2.85e-06	2.57e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	2.84e-06	2.57e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	2.84e-06	2.57e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.84e-06	2.57e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	2.84e-06	2.57e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	2.83e-06	2.56e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	2.83e-06	2.56e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	2.83e-06	2.56e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	2.82e-06	2.55e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	2.82e-06	2.55e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	2.82e-06	2.55e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	2.81e-06	2.54e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	2.81e-06	2.54e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.81e-06	2.54e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	2.79e-06	2.53e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	2.79e-06	2.52e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.79e-06	2.52e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.77e-06	2.5e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.75e-06	2.48e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	2.72e-06	2.46e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	2.71e-06	2.45e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—pancreatic cancer	2.69e-06	2.43e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	2.68e-06	2.42e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PIK3CA—pancreatic cancer	2.66e-06	2.41e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	2.66e-06	2.4e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—pancreatic cancer	2.64e-06	2.39e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—pancreatic cancer	2.64e-06	2.39e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	2.64e-06	2.39e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	2.63e-06	2.38e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	2.63e-06	2.38e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	2.63e-06	2.38e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—pancreatic cancer	2.63e-06	2.38e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	2.62e-06	2.37e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—pancreatic cancer	2.62e-06	2.37e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	2.62e-06	2.36e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.61e-06	2.36e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	2.6e-06	2.35e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	2.6e-06	2.35e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	2.59e-06	2.34e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	2.59e-06	2.34e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.59e-06	2.34e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	2.59e-06	2.34e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	2.59e-06	2.34e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	2.58e-06	2.33e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	2.57e-06	2.33e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—pancreatic cancer	2.57e-06	2.32e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	2.56e-06	2.32e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	2.54e-06	2.3e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.54e-06	2.29e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—pancreatic cancer	2.53e-06	2.28e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—pancreatic cancer	2.51e-06	2.27e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	2.51e-06	2.27e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—pancreatic cancer	2.5e-06	2.26e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	2.48e-06	2.25e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—APOE—pancreatic cancer	2.47e-06	2.23e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	2.46e-06	2.22e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.45e-06	2.22e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	2.44e-06	2.21e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	2.44e-06	2.2e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	2.43e-06	2.2e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	2.42e-06	2.19e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	2.4e-06	2.17e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	2.4e-06	2.17e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTEN—pancreatic cancer	2.39e-06	2.16e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	2.39e-06	2.16e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—pancreatic cancer	2.35e-06	2.13e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—pancreatic cancer	2.32e-06	2.1e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	2.29e-06	2.07e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	2.28e-06	2.06e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.26e-06	2.04e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	2.24e-06	2.03e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	2.24e-06	2.03e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	2.24e-06	2.03e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.23e-06	2.02e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.23e-06	2.01e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.23e-06	2.01e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	2.22e-06	2.01e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.21e-06	2e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—pancreatic cancer	2.21e-06	2e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.2e-06	1.99e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.19e-06	1.98e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—pancreatic cancer	2.17e-06	1.97e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—pancreatic cancer	2.17e-06	1.96e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	2.17e-06	1.96e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—pancreatic cancer	2.17e-06	1.96e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	2.16e-06	1.95e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—pancreatic cancer	2.15e-06	1.95e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.15e-06	1.94e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	2.13e-06	1.93e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	2.12e-06	1.92e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	2.11e-06	1.91e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	2.11e-06	1.91e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	2.08e-06	1.88e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	2.07e-06	1.87e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	2.07e-06	1.87e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	2.06e-06	1.86e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	2.04e-06	1.84e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.96e-06	1.77e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.91e-06	1.73e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—pancreatic cancer	1.87e-06	1.69e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	1.86e-06	1.69e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	1.83e-06	1.66e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—pancreatic cancer	1.83e-06	1.66e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	1.83e-06	1.65e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	1.82e-06	1.65e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	1.82e-06	1.64e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.8e-06	1.63e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.73e-06	1.56e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.71e-06	1.54e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.69e-06	1.53e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.69e-06	1.53e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.59e-06	1.44e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.48e-06	1.33e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.41e-06	1.28e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—pancreatic cancer	1.38e-06	1.25e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.35e-06	1.22e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.3e-06	1.18e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.1e-06	9.96e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.04e-06	9.41e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—pancreatic cancer	8.5e-07	7.69e-06	CbGpPWpGaD
